LUX IM Global Medtech E Cap EUR

The Fund seeks to provide capital growth over long term with a focus to companies related to the Health Care industry. The Fund is actively managed and it has no reference benchmark. The Fund will mainly invest in stocks issued by companies involved in the research, development, manufacture and distribution of products and services in the Biotechnology, Pharmaceutical, Life Sciences and Health Care related fields, without any limitation in terms of geographic, currency and market capitalization exposure. Small and micro capitalization companies will not represent more than 50% of the Fund's net assets. The Fund may also invest up to 10% of its net assets in target funds including exchange traded funds (ETFs). The Fund will not invest directly in securitized instruments including mortgage, asset backed securities (MBS / ABS), collateralized loan obligations (CLOs), collateralized mortgage obligations (CMOs) and CoCos. The Fund may use financial derivatives to protect its portfolio against unfavorable market or currency fluctuations. The Fund may also use financial derivatives to reduce other risks or to produce more revenues. The Fund is open-ended. You may redeem shares of the Fund on any Luxembourg business day.

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No